Reviva Pharmaceuticals Holdings Inc (NASDAQ:RVPH) currently has a daily average trading volume of 1.06M but it saw 3451228 shares traded in last market. With a market cap of 92.64M USD, the company’s current market price of $2.77 came falling about -1.60 while comparing to the previous closing price of $2.82. In past 52 weeks, the stock remained buoying in the range of price level as high as $5.67 and as low as $0.60. In the recent trading on the day, stock has struck highest price mark of $2.62 while lowest mark touched by it was $2.95.
Taking a look at 20-day trading activity of Reviva Pharmaceuticals Holdings Inc (RVPH) gives us an average price of $1.50, while its current price level is -51.15% below from 52-week high level whereas it is 361.67% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $1.30 while that of 200 days or SMA-200 reads an average of $1.76. A closer look into the stock’s movement over the week reveals that its volatility is standing at 45.90% during that period while stretching the period over a month that decreases to 20.81%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 84.77 which implies that the stock is in overbought territory.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the ROTH MKM which initiated the stock as “Buy” in its note to investors issued on September 20, 2023, recommending a price target of $12 for it. H.C. Wainwright also issued its recommendations for the stock as it initiated the price target for the stock is $10.
Over the week, RVPH’s stock price is moving 93.71% up while it is 109.85% when we observe its performance for the past one month. Year-to-date it is -46.21% down and over the past year, the stock is showing a downside performance of -30.92%.
The company is expected to be releasing its next quarterly report in January, for which analysts forecasted an EPS of -0.23 while estimate for next year EPS is -1.0.
Currently, Reviva Pharmaceuticals Holdings Inc’s total number of outstanding shares is 33.44M with 14.79% of that held by the insiders while 30.07% of its common stock has been owned by the institutions. Company’s return on equity (ROE) at -1806.28%. Stock’s beta reads -0.05. Its return on asset (ROA) is -512.93% on average.
